APA (7th ed.) Citation

Goodman, S. G., & Hacke, W. (2014). Factors associated with major bleeding events: Insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). Journal of the American College of Cardiology, 63(9), . https://doi.org/10.1016/j.jacc.2013.11.013

Chicago Style (17th ed.) Citation

Goodman, Shaun G., and Werner Hacke. "Factors Associated with Major Bleeding Events: Insights from the ROCKET AF Trial (rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." Journal of the American College of Cardiology 63, no. 9 (2014). https://doi.org/10.1016/j.jacc.2013.11.013.

MLA (9th ed.) Citation

Goodman, Shaun G., and Werner Hacke. "Factors Associated with Major Bleeding Events: Insights from the ROCKET AF Trial (rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." Journal of the American College of Cardiology, vol. 63, no. 9, 2014, https://doi.org/10.1016/j.jacc.2013.11.013.